DNA alkylation-induced damage

DNA alkylation-induced damage is not a discrete molecular target but rather describes a class of chemical modifications where an exogenous or endogenous agent transfers an alkyl group onto nucleophilic sites within the DNA. This results in various types of lesions—such as O6-methylguanine—that can block transcription and replication machinery. If unrepaired by cellular mechanisms like MGMT or base excision repair enzymes, these lesions lead to mutations or trigger apoptosis. Many chemotherapeutic drugs exploit this vulnerability by inducing extensive DNA damage specifically in rapidly dividing tumor cells; however, normal tissues are also affected. The effectiveness and safety profile depend heavily on the balance between drug-induced cytotoxicity in cancer versus healthy tissue and the capacity for tumor cells’ repair pathways. High expression levels of certain repair proteins confer resistance against these therapies.

Other names

DNA alkylationDNA damage by alkylating agentsAlkylated DNA lesionsCytotoxic DNA adducts

Drugs targeting this process act by: - Covalently attaching alkyl groups to specific positions on the DNA bases, leading to mispairing, strand breaks, transcriptional stalling, and ultimately cell death if the damage is not repaired. - Overwhelming tumor cell repair mechanisms to induce cytotoxicity.